Prognostic Value of Texture Analysis Based on Pretreatment DWI-Weighted MRI for Esophageal Squamous Cell Carcinoma Patients Treated With Concurrent Chemo-Radiotherapy

被引:9
|
作者
Li, Zhenjiang [1 ]
Han, Chun [2 ]
Wang, Lan [2 ]
Zhu, Jian [1 ]
Yin, Yong [1 ]
Li, Baosheng [1 ]
机构
[1] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Jinan, Shandong, Peoples R China
[2] Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2019年 / 9卷
基金
中国国家自然科学基金;
关键词
esophageal squamous cell cancer; texture analysis; magnetic resonance imaging; diffusion-weighted magnetic resonance imaging; chemo-radiotherapy; TUMOR HETEROGENEITY; RECTAL-CARCINOMA; REPRODUCIBILITY; CHEMORADIATION; FEATURES; STAGE;
D O I
10.3389/fonc.2019.01057
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The purpose of the research was to assess the prognostic value of three-dimensional (3D) texture features based on diffusion-weighted magnetic resonance imaging (DWI) for esophageal squamous cell carcinoma (ESCC) patients undergoing concurrent chemo-radiotherapy (CRT). Methods: We prospectively enrolled 82 patients with ESCC into a cohort study. Two DWI sequences (b = 0 and b = 600 s/mm(2)) were acquired along with axial T2WI and T1WI before CRT. Two groups of features were examined: (1) clinical and demographic features (e.g., TNM stage, age and sex) and (2) changes in spatial texture characteristics of the apparent diffusion coefficient (ADC), which characterizes gray intensity changes in tumor areas, spatial pattern and distribution, and related changes caused by CRT. Reproducible feature sets without redundancy were statistically filtered and validated. The prognostic values associated with overall survival (OS) for each parameter were studied using Kaplan-Meier and Cox regression models for univariate and multivariate analyses, respectively. Results: Both univariate and multivariate Cox model analyses showed that the energy of intensity histogram texture (IHIST_energy), radiation dose, mean of the contrast in distance 1 of 26 directions (m_contrast_1), extreme difference of the homogeneity in distance 2 of 26 directions (Diff_homogeneity_2), mean of the inverse variance in distance 2 of 26 directions (m_lnversevariance_2), high-intensity small zone emphasis (HISE), and low-intensity large zone emphasis (LILE) were significantly associated with survival. The results showed that 6 texture parameters extracted from the ADC images before treatment could distinguish among high-, medium-, and low-risk groups (log-rank chi(2) = 9.7; P = 0.00773). The biased C-index value was 0.715 (95% CI: 0.708 to 0.732) based on bootstrapping validation. Conclusions: The ADC 3D texture feature can be used as a useful biomarker to predict the survival of ESCC patients undergoing CRT. Combining ADC 3D texture features with conventional prognostic factors can generate reliable survival prediction models.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Cetuximab with radiotherapy in patients with loco-regionally advanced squamous cell carcinoma of head and neck unsuitable or ineligible for concurrent platinum-based chemo-radiotherapy: Ready for routine clinical practice?
    Agarwal, J. P.
    Gupta, T.
    Kalyani, N.
    Budrukkar, A.
    Laskar, S. G.
    Murthy, V
    Kumar, P.
    Narohna, V
    Pai, P.
    Chaturvedi, P.
    D'cruz, A. K.
    INDIAN JOURNAL OF CANCER, 2011, 48 (02) : 148 - 153
  • [42] PROGNOSIS OF DYNAMIC MR IMAGING AND DIFFUSION WEIGHTED IMAGING FOR STAGE III NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH CONCURRENT CHEMO-RADIOTHERAPY
    Li, Baosheng
    Wang, Yinxia
    Chen, Zhaoqiu
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 158 - 158
  • [43] Effectiveness of image-guided radiotherapy for locally advanced esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy
    Kuo, Yao-Hung
    Fang, Hsin-Yuan
    Lin, Yu-Sen
    Lein, Ming-Yu
    Yang, Chi-Ying
    Ho, Shih-Chi
    Li, Chia-Chin
    Chien, Chun-Ru
    THORACIC CANCER, 2020, 11 (01) : 113 - 119
  • [44] Prognostic values of the gross volume of metastatic lymph nodes in patients with esophageal squamous cell carcinoma treated with definitive concurrent chemoradiotherapy
    Li, Yang
    Li, Yanqi
    Huang, Hui
    Guo, Zhoubo
    Zhang, Kunning
    Zhang, Wencheng
    Pang, Qingsong
    Wang, Ping
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [45] Nimotuzumab plus concurrent chemo-radiotherapy versus chemo-radiotherapy in unresectable locally advanced esophageal squamous cell carcinoma (ESCC): Interim analysis from a prospective, randomized-controlled, double-blinded, multicenter, and phase III clinical trial (NXCEL1311 Study).
    Meng, Xue
    Zheng, Anping
    Wang, Jun
    Wang, Jianhua
    Li, Guang
    Zhu, Jun
    Ma, Hu
    Zhu, Xiaodong
    Shi, Anhui
    Dai, Chunhua
    Yan, Senxiang
    Wang, Buhai
    Qu, Zhongyu
    Han, Chun
    Sun, Xindong
    Ye, Ming
    Fan, Ruitai
    Huerxidan, Ni Yazi
    Wang, Xiaohong
    Yu, Jinming
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [46] Nimotuzumab plus concurrent chemo-radiotherapy in unresectable locally advanced oesophageal squamous cell carcinoma (ESCC): interim analysis from a Phase 3 clinical trial
    Meng, Xue
    Zheng, Anping
    Wang, Jun
    Wu, Xiaoyuan
    Li, Guang
    Zhu, Jun
    Ma, Hu
    Zhu, Xiaodong
    Shi, Anhui
    Dai, Chunhua
    Yan, Senxiang
    Wang, Buhai
    Qu, Zhongyu
    Han, Chun
    Sun, Xindong
    Ye, Ming
    Fan, Ruitai
    Huerxidan, Niyazi
    Wang, Xiaohong
    Yu, Jinming
    BRITISH JOURNAL OF CANCER, 2023, 129 (11) : 1787 - 1792
  • [47] Development of a prognostic nomogram for esophageal squamous cell carcinoma patients received radiotherapy based on clinical risk factors
    Li, Yang
    Shao, Xian
    Dai, Li-Juan
    Yu, Meng
    Cong, Meng-Di
    Sun, Jun-Yi
    Pan, Shuo
    Shi, Gao-Feng
    Zhang, An-Du
    Liu, Hui
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [48] Nimotuzumab plus concurrent chemo-radiotherapy in unresectable locally advanced oesophageal squamous cell carcinoma (ESCC): interim analysis from a Phase 3 clinical trial
    Xue Meng
    Anping Zheng
    Jun Wang
    Xiaoyuan Wu
    Guang Li
    Jun Zhu
    Hu Ma
    Xiaodong Zhu
    Anhui Shi
    Chunhua Dai
    Senxiang Yan
    Buhai Wang
    Zhongyu Qu
    Chun Han
    Xindong Sun
    Ming Ye
    Ruitai Fan
    Niyazi Huerxidan
    Xiaohong Wang
    Jinming Yu
    British Journal of Cancer, 2023, 129 : 1787 - 1792
  • [49] MRI T2-weighted sequences-based texture analysis (TA) as a predictor of response to neoadjuvant chemo-radiotherapy (nCRT) in patients with locally advanced rectal cancer (LARC)
    Crimi, Filippo
    Capelli, Giulia
    Spolverato, Gaya
    Bao, Quoc Riccardo
    Florio, Anna
    Milite Rossi, Sebastiano
    Cecchin, Diego
    Albertoni, Laura
    Campi, Cristina
    Pucciarelli, Salvatore
    Stramare, Roberto
    RADIOLOGIA MEDICA, 2020, 125 (12): : 1216 - 1224
  • [50] MRI T2-weighted sequences-based texture analysis (TA) as a predictor of response to neoadjuvant chemo-radiotherapy (nCRT) in patients with locally advanced rectal cancer (LARC)
    Filippo Crimì
    Giulia Capelli
    Gaya Spolverato
    Quoc Riccardo Bao
    Anna Florio
    Sebastiano Milite Rossi
    Diego Cecchin
    Laura Albertoni
    Cristina Campi
    Salvatore Pucciarelli
    Roberto Stramare
    La radiologia medica, 2020, 125 : 1216 - 1224